Literature DB >> 9128739

Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene.

R Netzker1, C Weigert, K Brand.   

Abstract

Site-directed mutagenesis of cis-regulatory elements in the 5' flanking region of the rat pyruvate kinase M gene revealed that two out of the three GC boxes (-133/-124 and -48/-39) are involved in the stimulation of a core promoter (-35/+46). These two regions were also protected in DNaseI footprinting assays. Sp1 and Sp3 were identified as binding proteins to all three GC boxes by supershift experiments. Cotransfections in Drosophila SL2 cells revealed a strong stimulatory function of Sp1 and a synergistic effect of Sp3 to Sp1 in the activation of the pyruvate kinase M promoter. No inhibitory effect of Sp3 was detected. These data indicate that binding of Sp1 at two GC boxes is required for full promoter activity of the pyruvate kinase M gene and thus contributes to the observed cell-cycle-dependent expression of this enzyme in proliferating rat thymocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128739     DOI: 10.1111/j.1432-1033.1997.00174.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Expression of the rat liver carnitine palmitoyltransferase I (CPT-Ialpha) gene is regulated by Sp1 and nuclear factor Y: chromosomal localization and promoter characterization.

Authors:  M L Steffen; W R Harrison; F F Elder; G A Cook; E A Park
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 2.  Regulation and function of pyruvate kinase M2 in cancer.

Authors:  Weiwei Yang; Zhimin Lu
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

Review 3.  Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield.

Authors:  K Brand
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 4.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

5.  Different Sp1 family members differentially affect transcription from the human elongation factor 1 A-1 gene promoter.

Authors:  S J Nielsen; M Praestegaard; H F Jorgensen; B F Clark
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 6.  Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer.

Authors:  Gopinath Prakasam; Mohammad Askandar Iqbal; Rameshwar N K Bamezai; Sybille Mazurek
Journal:  Front Oncol       Date:  2018-02-07       Impact factor: 6.244

7.  Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.

Authors:  Jane Gilmour; Leigh O'Connor; Christopher P Middleton; Peter Keane; Nynke Gillemans; Jean-Baptiste Cazier; Sjaak Philipsen; Constanze Bonifer
Journal:  Epigenetics Chromatin       Date:  2019-06-04       Impact factor: 4.954

8.  Metformin: Possible Use of a Diabetes Drug in Treatment of Cancer.

Authors:  Albert Vacheron; Anne Wynn; Jeff Zuber; Solomon S Solomon
Journal:  Clin Res Diabetes Endocrinol       Date:  2018

9.  Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells.

Authors:  Beatrice E Bachmeier; Cristina M Iancu; Peter H Killian; Emanuel Kronski; Valentina Mirisola; Giovanna Angelini; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

10.  Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.

Authors:  Daniela Gasperíková; Nicolas D Tribble; Juraj Staník; Miroslava Hucková; Nadezda Misovicová; Martijn van de Bunt; Lucia Valentínová; Beryl A Barrow; L'ubomir Barák; Radoslav Dobránsky; Eva Bereczková; Jozef Michálek; Kate Wicks; Kevin Colclough; Julian C Knight; Sian Ellard; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-05-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.